(Q37852633)

24 August 2017

title

Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study (English)

1 reference

24 August 2017

Laura Kranaster

1

1 reference

24 August 2017

Jutta Kammerer-Ciernioch

series ordinal

2

1 reference

24 August 2017

Carolin Hoyer

series ordinal

3

1 reference

24 August 2017

Alexander Sartorius

series ordinal

4

1 reference

24 August 2017

publication date

13 March 2011

1 reference

European Archives of Psychiatry and Clinical Neuroscience

24 August 2017

published in

1 reference

24 August 2017

volume

261

1 reference

24 August 2017

issue

8

1 reference

24 August 2017

page(s)

575-582

1 reference

Anaesthesia in haemodynamically compromised emergency patients: does ketamine represent the best choice of induction agent?

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Anesthesia for electroconvulsive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Oral administration of the NMDA receptor antagonist S-ketamine as add-on therapy of depression: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Ketamine As an Anaesthetic for Ect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Ketamine (“Ketalar”): A Safer Anaesthetic for ECT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Influence of anesthetic drugs and concurrent psychiatric medication on seizure adequacy during electroconvulsive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Augmentation strategies in electroconvulsive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

The difficult-to-treat electroconvulsive therapy patient - Strategies for augmenting outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Antidepressant effect of ketamine during ECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Ketamine appears associated with better word recall than etomidate after a course of 6 electroconvulsive therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

ECT anesthesia: the lighter the better?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Sympathomimetic effects of low-dose S(+)-ketamine. Effect of propofol dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Side effects of ketamine in the long-term treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Electrode placement in electroconvulsive therapy (ECT): A review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Impact of sociodemographic and health variables on mini-mental state examination in a community-based sample of older people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

ECS-Induced mossy fiber sprouting and BDNF expression are attenuated by ketamine pretreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Ketamine pre-treatment dissociates the effects of electroconvulsive stimulation on mossy fibre sprouting and cellular proliferation in the dentate gyrus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Seizures, memory and synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-011-0205-7

Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT.

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/21400226

12 December 2020

Ketamine for the treatment of chronic non-cancer pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/21400226

12 December 2020

Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/21400226

12 December 2020

Retrograde amnesia for spatial memory induced by NMDA receptor-mediated long-term potentiation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21400226

12 December 2020

The sigma enigma: can sigma receptors provide a novel target for disorders of mood and cognition?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21400226

12 December 2020

The use of a series of ketamine infusions in two patients with treatment-resistant depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/21400226

12 December 2020

Cognitive functioning in severe psychiatric disorders: a general population study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21400226

12 December 2020

10.1007/S00406-011-0205-7

Identifiers

DOI

1 reference

24 August 2017

1 reference